Epstein Secrets

n confided in him. saying. for example. that he had left Bear Stearns in 1981 after he was discovered ex- ecuting "illegal operations." Several of Epsteiris bear Stearns contem- poraries recall that Epstein left the compa- ny very• suddenly. Within the company there were rumors also that he was involved

ho declined comment. Epstein is the president of J Epstein & Co., a money management company based in Manh

, Larry Visoski Flight Engineer: Larry Morrison DATE; - eJ , 2005 FROM r F K TO e /3 I 2. Departure AM rime : 2y PASSENGERS 1. Jeffrey Epstein G. A 1..c 3. 7),9•1,/dab 4. 4/04 11'1 .lam fr./ ozg 5, itiA, de, %. c ). 4 6. 7. 8. 9. 10. 11. 12- 13. 14.

owned by Wexner's even more mysterious protégé, Jeffrey E. Epstein. Epstein, who recently loaned his jet t

ult. They decided to use the press to embarrass Mr. Epstein." But records show that Reiter wrote Krischer o

C. PASSENGER MANIFEST Registration Number- N908.JE Type: B-727-31 Pilots: Dave Rodgers, Larry Wr

owned by Wexner's even more mysterious protégé, Jeffrey E. Epstein. Epstein, who recently loaned his jet to

ations John A. Georges, Senior Managing Director, Windward Capital Partners, L.P; former Chairman and Chief Executive Officer, International Paper David R. Gergen, Editor-at-Large, U.S. News and World Report; former Special Advisor to the U.S. President and Secretary of State Louis V. Gerstner, Jr., Chairman

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

eicke Jurgen M. Geissinger Paul Geitner Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersemann Minelik Getahun Aart J. Geus Federico Ghizzoni Carlos

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Feder

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Feder

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

ting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Olaf Gersemann Alan Gershenhorn Minelik Alemu Getahun Aart J. de Geus Carlos Ghosn Huda Al Ghoson Majid S.

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

HOUSE_OVERSIGHT_017075 --- PAGE BREAK --- Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersemann Minelik Getahun Aart J. de Geus Federico Ghizzoni Carlos Gh